Holen Sie sich die Stockscreener-App
0.51
2.62%
0.013
Handel nachbörslich:
.53
0.02
+3.92%
Schlusskurs vom Vortag:
$0.497
Offen:
$0.5102
24-Stunden-Volumen:
711.86K
Relative Volume:
1.43
Marktkapitalisierung:
$9.36M
Einnahmen:
$7.19M
Nettoeinkommen (Verlust:
$-50.08M
KGV:
-0.00178
EPS:
-286.9
Netto-Cashflow:
$-48.33M
1W Leistung:
-14.14%
1M Leistung:
-63.57%
6M Leistung:
-90.96%
1J Leistung:
-86.92%
1-Tages-Spanne:
$0.51
$0.5489
1-Wochen-Bereich:
$0.4417
$0.5922
52-Wochen-Spanne:
$0.4417
$8.3799
T 2 Biosystems Inc Stock (TTOO) Company Profile
Firmenname
T 2 Biosystems Inc
Sektor
Branche
Telefon
781-457-1200
Adresse
101 HARTWELL AVENUE, LEXINGTON
Vergleichen Sie TTOO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| TTOO | 0.51 | 9.36M | 7.19M | -50.08M | -48.33M | -286.90 |
| TMO | 501.29 | 192.46B | 42.37B | 6.14B | 7.78B | 15.26 |
| DHR | 230.06 | 166.23B | 23.74B | 3.89B | 4.98B | 7.93 |
| A | 126.92 | 36.47B | 6.50B | 1.41B | 1.42B | 3.82 |
| IQV | 191.04 | 34.67B | 15.32B | 1.41B | 1.96B | 5.95 |
| IDXX | 419.83 | 34.38B | 3.84B | 866.24M | 792.60M | 9.80 |
T 2 Biosystems Inc Stock (TTOO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-01-27 | Herabstufung | Alliance Global Partners | Buy → Neutral |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2019-11-26 | Herabstufung | Janney | Buy → Neutral |
| 2019-08-01 | Herabstufung | Alliance Global Partners | Buy → Neutral |
| 2019-07-31 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2019-07-31 | Herabstufung | Janney | Buy → Neutral |
| 2019-05-16 | Eingeleitet | Alliance Global Partners | Buy |
| 2019-03-08 | Bestätigt | H.C. Wainwright | Buy |
| 2018-06-01 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-05-30 | Bestätigt | H.C. Wainwright | Buy |
| 2018-05-29 | Bestätigt | WBB Securities | Strong Buy |
| 2018-03-29 | Bestätigt | H.C. Wainwright | Buy |
| 2018-01-29 | Eingeleitet | Goldman | Neutral |
| 2017-10-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-03-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2016-11-10 | Fortgesetzt | Leerink Partners | Mkt Perform |
| 2016-11-02 | Bestätigt | Cantor Fitzgerald | Buy |
| 2016-07-20 | Hochstufung | WBB Securities | Buy → Strong Buy |
| 2016-06-22 | Hochstufung | WBB Securities | Speculative Buy → Buy |
| 2016-04-12 | Bestätigt | Canaccord Genuity | Buy |
| 2016-02-17 | Eingeleitet | WBB Securities | Speculative Buy |
Alle ansehen
T 2 Biosystems Inc Aktie (TTOO) Neueste Nachrichten
T2 Biosystems Reports Strong Q3 Financial Results and Operational Updates - Defense World
T2 Biosystems, Inc. (NASDAQ:TTOO) Q3 2024 Earnings Call Transcript - Insider Monkey
T2 Biosystems: Q3 Earnings Snapshot - mySA
Earnings call: T2 Biosystems reports growth and strategic partnerships - Investing.com
T2 Biosystems Inc (TTOO) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ... - Yahoo Finance
Analysis of ARMISTICE CAPITAL, LLC's Recent Trade in T2 Biosyste - GuruFocus.com
T2 Biosystems Reports Increased Losses and Cash Crunch - TipRanks
T2 Biosystems Inc (TTOO) Quarterly 10-Q Report - Quartzy
T2 Biosystems Announces Third Quarter 2024 Financial Results - The Manila Times
T2 Biosystems Reports 34% Revenue Growth, Signs Cardinal Health Distribution Deal | TTOO Stock News - StockTitan
T2 Biosystems stock plunges to 52-week low of $0.55 By Investing.com - Investing.com Canada
500: Something went wrong - Investing.com
T2 Biosystems Faces Potential Delisting from Nasdaq due to Market Value - Defense World
T2 Biosystems (TTOO) Scheduled to Post Earnings on Thursday - Defense World
T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024 - GlobeNewswire
T2 Biosystems Forges Sales Deal With Cardinal Health for Sepsis Test - MPO-mag
T2 Biosystems stock plunges to 52-week low of $0.81 - Investing.com
T2 Biosystems stock plunges to 52-week low at $1.08 By Investing.com - Investing.com Australia
T2 Biosystems stock plunges to 52-week low at $1.08 - Investing.com
T2 Biosystems stock plunges to 52-week low of $1.37 - Investing.com
T2 Biosystems stock plunges to 52-week low of $1.37 By Investing.com - Investing.com UK
T2 Biosystems reports progress in product pipeline By Investing.com - Investing.com South Africa
T2 Biosystems reports progress in product pipeline - Investing.com India
Earnings call: T2 Biosystems reports Q3 revenue growth, new partnerships By Investing.com - Investing.com South Africa
Earnings call: T2 Biosystems reports Q3 revenue growth, new partnerships - Investing.com
T2 Biosystems stock plunges to 52-week low of $1.53 - Investing.com
T2 Biosystems stock plunges to 52-week low of $1.53 By Investing.com - Investing.com UK
CAH Stock May Gain Following the Distribution Deal With T2 Biosystems - Yahoo Finance
T2 Biosystems to Host Business Update Call on October 10, 2024 - ForexTV.com
T2 Biosystems and Prxcision announce sepsis solution collaboration By Investing.com - Investing.com South Africa
T2 Biosystems and Prxcision announce sepsis solution collaboration - Investing.com India
T2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing Collaboration for Rapid Direct-From-Blood Diagnostics and AI-Powered Decision Support Platform - The Manila Times
T2 Biosystems, Inc. and Prxcision, Inc. Announce - GlobeNewswire
Market Watch: T2 Biosystems Inc (TTOO)’s Noteworthy Drop, Closing at 1.63 - The Dwinnex
T2 Biosystems reports 35% revenue growth in Q3 - Investing.com
T2 Biosystems reports 35% revenue growth in Q3 By Investing.com - Investing.com South Africa
T2 Biosystems secures exclusive deal with Cardinal Health - Investing.com
T2 Biosystems Announces Preliminary Third Quarter 2024 Financial Results - The Manila Times
T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens - The Manila Times
T2 Biosystems secures exclusive deal with Cardinal Health By Investing.com - Investing.com Australia
T2 Biosystems Announces Exclusive U.S. Agreement with - GlobeNewswire
Finanzdaten der T 2 Biosystems Inc-Aktie (TTOO)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.04%
3.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):